325 related articles for article (PubMed ID: 9815270)
21. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of κ-carrageenan on oxazolone-induced inflammation in BALB/c mice.
Wu W; Wang F; Gao X; Niu T; Zhu X; Yan X; Chen H
BMC Gastroenterol; 2016 Mar; 16():41. PubMed ID: 27015810
[TBL] [Abstract][Full Text] [Related]
23. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses.
Dohi T; Fujihashi K; Rennert PD; Iwatani K; Kiyono H; McGhee JR
J Exp Med; 1999 Apr; 189(8):1169-80. PubMed ID: 10209035
[TBL] [Abstract][Full Text] [Related]
24. Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein.
Nguyen DD; Maillard MH; Cotta-de-Almeida V; Mizoguchi E; Klein C; Fuss I; Nagler C; Mizoguchi A; Bhan AK; Snapper SB
Gastroenterology; 2007 Oct; 133(4):1188-97. PubMed ID: 17764675
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of oxazolone-induced colitis and survival improvement by vagus nerve stimulation.
Meroni E; Stakenborg N; Gomez-Pinilla PJ; De Hertogh G; Goverse G; Matteoli G; Verheijden S; Boeckxstaens GE
PLoS One; 2018; 13(5):e0197487. PubMed ID: 29791477
[TBL] [Abstract][Full Text] [Related]
26. Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency interleukin-2Rγ(null) mice engrafted with human peripheral blood mononuclear cells.
Nolte T; Zadeh-Khorasani M; Safarov O; Rueff F; Gülberg V; Herbach N; Wollenberg A; Mueller T; Siebeck M; Wolf E; Gropp R
Clin Exp Immunol; 2013 May; 172(2):349-62. PubMed ID: 23574330
[TBL] [Abstract][Full Text] [Related]
27. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
[TBL] [Abstract][Full Text] [Related]
28. Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages.
Reyes JL; Wang A; Fernando MR; Graepel R; Leung G; van Rooijen N; Sigvardsson M; McKay DM
J Immunol; 2015 Jan; 194(1):364-78. PubMed ID: 25452561
[TBL] [Abstract][Full Text] [Related]
29. Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a type 2 immune response.
Cenac N; Cellars L; Steinhoff M; Andrade-Gordon P; Hollenberg MD; Wallace JL; Fiorucci S; Vergnolle N
Inflamm Bowel Dis; 2005 Sep; 11(9):792-8. PubMed ID: 16116312
[TBL] [Abstract][Full Text] [Related]
30. The role of IL-13 and NK T cells in experimental and human ulcerative colitis.
Fuss IJ; Strober W
Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S31-3. PubMed ID: 19079225
[TBL] [Abstract][Full Text] [Related]
31. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.
Schiechl G; Bauer B; Fuss I; Lang SA; Moser C; Ruemmele P; Rose-John S; Neurath MF; Geissler EK; Schlitt HJ; Strober W; Fichtner-Feigl S
J Clin Invest; 2011 May; 121(5):1692-708. PubMed ID: 21519141
[TBL] [Abstract][Full Text] [Related]
32. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
33. Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.
El-Mahdy NA; El-Sayad ME; El-Kadem AH; Abu-Risha SE
Fundam Clin Pharmacol; 2021 Feb; 35(1):143-155. PubMed ID: 32383169
[TBL] [Abstract][Full Text] [Related]
34. IL-4 exacerbates disease in a Th1 cell transfer model of colitis.
Fort M; Lesley R; Davidson N; Menon S; Brombacher F; Leach M; Rennick D
J Immunol; 2001 Feb; 166(4):2793-800. PubMed ID: 11160346
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic activity of an interleukin-4/interleukin-13 dual antagonist on oxazolone-induced colitis in mice.
Kasaian MT; Page KM; Fish S; Brennan A; Cook TA; Moreira K; Zhang M; Jesson M; Marquette K; Agostinelli R; Lee J; Williams CM; Tchistiakova L; Thakker P
Immunology; 2014 Nov; 143(3):416-27. PubMed ID: 24831554
[TBL] [Abstract][Full Text] [Related]
36. A Protective Role of NOD2 on Oxazolone-induced Intestinal Inflammation Through IL-1β-mediated Signalling Pathway.
Secher T; Couturier A; Huot L; Bouscayrol H; Grandjean T; Boulard O; Hot D; Ryffel B; Chamaillard M
J Crohns Colitis; 2023 Jan; 17(1):111-122. PubMed ID: 35917251
[TBL] [Abstract][Full Text] [Related]
37. Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis.
Galitovskiy V; Qian J; Chernyavsky AI; Marchenko S; Gindi V; Edwards RA; Grando SA
J Immunol; 2011 Sep; 187(5):2677-87. PubMed ID: 21784975
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-36β exacerbates DSS-induce acute colitis via inhibiting Foxp3
Zhu J; Xu Y; Li Z; Liu S; Fu W; Wei Y
Int Immunopharmacol; 2022 Jul; 108():108762. PubMed ID: 35436743
[TBL] [Abstract][Full Text] [Related]
40. Proinflammatory role of basophils in oxazolone-induced chronic intestinal inflammation.
Inaba K; Higashiyama M; Watanabe C; Tomioka A; Ito S; Tanemoto R; Mizoguchi A; Nishii S; Wada A; Sugihara N; Hanawa Y; Horiuchi K; Akita Y; Okada Y; Kurihara C; Narimatsu K; Komoto S; Tomita K; Karasuyama H; Satoh T; Hokari R
J Gastroenterol Hepatol; 2022 Sep; 37(9):1768-1775. PubMed ID: 35877196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
